Patients’ self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study

Patients’ self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study

Abstract Background Early intervention to reduce the impact of adverse events (AEs) may improve patients’ quality of life and enable optimal treatment duration. Methods This nationwide, multicenter, prospective, longitudinal, 1-year observational study investigated patients’ self-management of AEs a...

Full description

Bibliographic Details
Main Authors: Sung-Hoo Hong, Ho Seok Chung, Ill-Young Seo, Tae Gyun Kwon, Hyeon Jeong, Jae-Il Chung, Seung Hyun Jeon, Jae Young Park, Hong Koo Ha, Byung-Ha Chung, Wan Song, Young-Joo Kim, Sang-Hee Kim, Jee-Sun Lee, Juneyoung Lee, Jinsoo Chung
Format: Article
Language:English
Published: SpringerOpen 2022-12-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Self-management
Side effects and adverse reactions
Molecular targeted therapy
Carcinoma
Renal cell
Patient reported outcome measures
Online Access:https://doi.org/10.1186/s41687-022-00532-0

Similar Items

Similar Items